Results for
"[search-keyword]"
Sponsor content
29 result(s) found, displaying 1 to 10
-
Designation or determinationProvisional determination
-
-
Jul-2024Prescription medicine evaluationActive ingredient: omaveloxolone.
-
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Australian Public Assessment Report (AusPAR)AusPAR for withdrawn Aduhelm (aducanumab) for proposed treatment of Alzheimer’s disease.
-
Australian Public Assessment Report (AusPAR)New AusPAR for VUMERITY (diroximel fumarate) to reduce relapses and delay progression of disability in multiple sclerosis patients.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VUMERITY diroximel fumarate 231 mg enteric capsules bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe.
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd